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Infection with human and simian immunodeficiency viruses (HIV/
SIV) requires binding of the viral envelope glycoprotein (Env) to
the host protein CD4 on the surface of immune cells. Although
invariant in humans, the Env binding domain of the chimpanzee
CD4 is highly polymorphic, with nine coding variants circulating in
wild populations. Here, we show that within-species CD4 diversity
is not unique to chimpanzees but found in many African primate
species. Characterizing the outermost (D1) domain of the CD4 pro-
tein in over 500 monkeys and apes, we found polymorphic resi-
dues in 24 of 29 primate species, with as many as 11 different
coding variants identified within a single species. D1 domain
amino acid replacements affected SIV Env-mediated cell entry in
a single-round infection assay, restricting infection in a strain- and
allele-specific fashion. Several identical CD4 polymorphisms, in-
cluding the addition of N-linked glycosylation sites, were found
in primate species from different genera, providing striking exam-
ples of parallel evolution. Moreover, seven different guenons (Cer-
copithecus spp.) shared multiple distinct D1 domain variants,
pointing to long-term trans-specific polymorphism. These data in-
dicate that the HIV/SIV Env binding region of the primate CD4
protein is highly variable, both within and between species, and
suggest that this diversity has been maintained by balancing se-
lection for millions of years, at least in part to confer protection
against primate lentiviruses. Although long-term SIV-infected spe-
cies have evolved specific mechanisms to avoid disease progres-
sion, primate lentiviruses are intrinsically pathogenic and have left
their mark on the host genome.
CD4 | primate lentiviruses | parallel evolution | trans-specific
polymorphism | balancing selection
Simian immunodeficiency viruses (SIVs) comprise a largegroup of lentiviruses that infect over 45 African primate
species, including numerous guenons (Cercopithecus spp.), Afri-
can green monkeys (Chlorocebus spp.), mandrills and drills
(Mandrillus spp.), mangabeys (Cercocebus spp.), colobus mon-
keys (Colobus spp., Piliocolobus spp.), as well as chimpanzees
(Pan troglodytes) and western gorillas (Gorilla gorilla) (1). Al-
though the prevalence rates and geographic distribution of these
infections vary widely, most SIVs are host-specific (i.e., their
genomes form species-specific clusters in phylogenetic trees)
(2–5). This has enabled the identification of instances when SIVs
have crossed species barriers, including from apes and monkeys
to humans (6). Phylogenetic analyses have shown that both
pandemic and nonpandemic forms of HIV type 1 (HIV-1)
resulted from the cross-species transmission of SIVs infecting
central chimpanzees (P. troglodytes troglodytes) and western
lowland gorillas (G. gorilla gorilla), while the various groups of
HIV type 2 (HIV-2) emerged following the transfer of SIVsmm
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strains naturally infecting sooty mangabeys (Cercocebus atys)
(6–9).
SIVs have also jumped between nonhuman primate species,
generating new SIV lineages. Cross-species transmission and
recombination between ancestors of viruses today infecting
greater spot-nosed (Cercopithecus nictitans), mustached (Cerco-
pithecus cephus) and mona (Cercopithecus mona) monkeys
(SIVgsn/SIVmus/SIVmon), and SIVrcm infecting red-capped
mangabeys (Cercocebus torquatus) gave rise to SIVcpz in chim-
panzees (10), and onward transmission of this virus to western
lowland gorillas generated SIVgor (11). Additional cross-species
transmissions and recombination events have generated mosaic
SIV lineages in green monkeys (Chlorocebus sabaeus) and
mandrills (Mandrillus sphinx) (12, 13). Finally, repeated intro-
ductions of diverse SIVs into the same primate species have
resulted in cocirculating lineages, such as SIVkcol1 and SIVk-
col2 in Kibale black-and-white colobus (Colobus guereza), and
SIVmus-1, SIVmus-2, and SIVmus-3 in mustached monkeys (14,
15). Thus, primate lentiviruses have a high propensity to cross
species barriers and have done so on numerous occasions
throughout their evolutionary history.
Lentiviruses have existed for tens of millions of years as evi-
denced by the finding of endogenous viruses in the genomes of
species from four orders of mammals, including lemurs (16, 17),
colugos (18), rabbits (19, 20), and weasels (21, 22). Some SIVs,
such as those infecting green monkeys (Chlorocebus spp.) (23,
24) and the lhoesti group of guenons (Allochrocebus spp.) (25, 26)
are at least several million years old because they appear to have
coevolved with their respective hosts since these diverged from a
common ancestor. Although an upper limit of 6 to 10 million y
has been suggested for SIVs based on the fact that they have so
far been found only in African, but not Asian, lineages of Old
World monkeys (6), certain features of antiviral defense genes
suggest that monkeys may have been exposed to lentiviruses long
before this (27). Cellular restriction factors, such as APOBEC3G
and TRIM5, are exquisitely antiviral and are counteracted by
dedicated SIV accessary proteins. These restriction factors have
evolved under strong positive selection at sites specifically in-
volved in the interaction with lentiviruses, in both African and
Asian monkeys (28, 29). However, if SIV indeed infected the
common ancestor of African and Asian monkeys, this would
imply numerous subsequent infection losses from multiple host
lineages. Thus, it remains unclear when lentiviruses first
infected primates.
Among lentiviruses, those infecting primates are unique in
their use of the CD4 receptor for entry into target cells. The viral
envelope glycoprotein (Env) interacts with CD4 and subse-
quently undergoes conformational changes to expose the cor-
eceptor binding site, which is required for viral–cell membrane
fusion (30). CD4 is an immunoglobulin-like integral membrane
protein that is expressed on multiple immune cells and stabilizes
the interaction of the T cell receptor (TCR) with major histo-
compatibility complex class II (MHC II) molecules (31, 32). The
most outward domain of CD4 (the D1 domain) binds a non-
polymorphic region on MHC II, which enhances TCR signaling
(32). Importantly, the D1 domain is also the region that is bound
by the HIV/SIV Env glycoprotein (33, 34). In HIV-infected
humans and SIVmac-infected macaques, continuous high level
viral replication leads to CD4+ T cell depletion, systemic im-
mune activation, T cell exhaustion, and the development of
AIDS (35, 36). Naturally occurring SIVs can also cause immu-
nodeficiency and disease, as shown for chimpanzees and man-
drills (37–40), indicating that these viruses are intrinsically
pathogenic (41–43). However, a number of primate species with
presumed longstanding SIV infections, such as African green
monkeys, sooty mangabeys, and Ugandan red colobus monkeys
(Piliocolobus tephrosceles), have evolved unique mechanisms that
prevent disease progression despite continuous high viral
replication (44–48). While the time required to evolve these
adaptations is unknown, such protective mechanisms are absent
from hosts that acquire new SIV infections.
Unlike restriction factors, which prevent or limit viral repli-
cation, CD4 is a dependency factor (i.e., a host protein that is
required for successful infection). Since there are many examples
of host receptors coevolving with pathogens (49–51), it has been
assumed that pressures exerted by pathogenic SIVs are respon-
sible for the rapid diversification of primate CD4 (52–54).
However, direct evidence for this hypothesis has been lacking.
Examining the functional consequences of CD4 diversity in
chimpanzees, we recently found that naturally occurring amino
acid replacements in the D1 domain were able to inhibit SIVcpz
infection, both in vitro and in vivo (55). Protective mechanisms
included charged residues at the CD4–Env interface and steric
hindrance between CD4- and Env-encoded glycans, which were
effective not only against SIVcpz but also other SIVs that
chimpanzees frequently encounter. These results suggested that
CD4 diversity protects wild chimpanzee populations from SIV
infection, possibly by conferring a heterozygote advantage (55).
Since humans lack polymorphisms and glycans in the D1 domain,
we asked whether CD4 diversification was a unique adaptation
of chimpanzees. Sequencing the D1 domain in members of 36
African primate species, we identified a remarkable degree of
CD4 diversity, both within and between species. The observed
polymorphisms altered the cell entry of a panel of diverse SIV
Envs, with the level of restriction depending on the particular
allele and virus strain analyzed. Thus, the diversification of the
primate CD4 receptor appears to have resulted from an ancient
arms race between primate lentiviruses and their hosts.
Results
Bonobos Exhibit Limited CD4 Diversity. The CD4 receptor of
chimpanzees contains amino acid substitutions at positions 25
(Q/R), 40 (Q/R), 52 (N/K), 55 (V/I), and 68 (P/T), all of which
are the result of single nucleotide polymorphisms (SNPs) in
exons 2 and 3 (55). These SNPs result in nine coding variants of
the D1 domain, which appear to have evolved from an ancestral
CD4 allele (QQNVP) by point mutation and recombination
(55). Since bonobos (Pan paniscus) are the closest genetic rela-
tives of chimpanzees (56), we asked whether they share CD4
polymorphisms. Bonobos live in the rain forests of the Demo-
cratic Republic of the Congo (DRC) south of the Congo River
(SI Appendix, Fig. S1), and like chimpanzees, hunt and consume
other primates (57); however, unlike chimpanzees, they do not
appear to be SIV-infected (58). Extracting CD4 sequences from
publicly available bonobo genome libraries (56), we obtained
14 full-length protein sequences, 13 of which were identical and
differed from the ancestral chimpanzee QQNVP allele by a
single amino acid replacement (Q429E) in the cytoplasmic do-
main (one sequence contained an additional R240W replace-
ment in the D3 domain) (SI Appendix, Fig. S2). These results
suggested that bonobos lack polymorphisms in the D1 domain.
To determine the full extent of the bonobo CD4 diversity, we
used fecal samples from wild populations collected previously for
molecular epidemiological studies of SIVcpz and ape malaria
(58, 59). Specimens were available from 86 genotyped individ-
uals sampled at 8 field sites (SI Appendix, Table S1), including
from a genetically isolated population (TL) east of the Lomami
River (SI Appendix, Fig. S1). Since the CD4 gene is comprised of
multiple exons and introns spanning nearly 20 Kb on chromo-
some 12, we limited our analysis to exons 2 (165 bp) and 3 (159
bp), which together encode the entire D1 domain. Each exon
was amplified separately because of a large intervening intron
(>13 Kb) and sequenced without fragmentation to maintain
linkage between polymorphic sites. In addition, each exon was
amplified up to eight times to exclude allelic dropout (SI Ap-
pendix, Table S1). While exon 2 sequences were identical in all
2 of 12 | PNAS Russell et al.





















animals, exon 3 sequences differed by a single nonsynonymous
substitution, which led to an amino acid replacement at position
83 (I83T) (Fig. 1A). This polymorphism was located at the pe-
riphery of the Env binding region at a site not previously
reported to be under positive selection (Fig. 1B). Among the
animals studied, the T83 variant was relatively uncommon
(found in 14 bonobos at 4 field sites), while the I83 variant
represented the predominant form (found in 72 bonobos at all
field sites) (Fig. 1C and SI Appendix, Fig. S1). Thus, in contrast
to chimpanzees, bonobos exhibit limited D1 domain diversity,
with only two coding variants circulating in wild populations
(Table 1), the most common of which represents the inferred
ancestral CD4 allele of both chimpanzees and bonobos.
Although not naturally infected with SIV, bonobos are likely
exposed to primate lentiviruses through their hunting behavior
(57). Since the viruses infecting these prey species have not been
characterized, we selected a panel of SIV Envs from diverse viral
lineages and tested their ability to mediate entry into cells
expressing the bonobo CD4 receptors (8, 11, 55). These included
Envs from various SIVcpz and SIVgor strains, as well as SIVs
infecting mustached monkeys, red-tailed monkeys (SIVasc;





Fig. 1. Allelic diversity of CD4 in bonobos. (A) CD4 coding variants identified in wild bonobo populations. D1 domain variants of bonobos (P. paniscus, Pp;
derived from exon 2 and 3 sequences) are compared to human and chimpanzee CD4, with dots indicating identity to the human reference. A single amino
acid replacement (I83T) in the bonobo CD4 is boxed. A potential N-linked glycosylation site is indicated by asterisks. The ancestral chimpanzee (P. troglodytes;
Pt) allele is shown for reference, with positions that are polymorphic in chimpanzees underlined. (B) Crystal structure of the HIV-1 gp120 envelope domain
(black) bound to human CD4 (gray) (PDB ID code 4R2G), with polymorphic positions indicated for chimpanzees (blue) and bonobos (green). (C) CD4 allele
frequency in wild bonobos. The number of tested individuals is indicated. (D) Effects of bonobo CD4 polymorphisms on SIV Env mediated cell entry. The
infectivity of pseudoviruses carrying different SIV Envs is shown for transiently transfected cells expressing human and bonobo CD4 variants and the cognate
CC5 receptors. Values are scaled relative to the human CD4 (set to 100%). Bars represent the average of three independent transfections, each performed in
triplicate, with SDs shown (fold-changes of Env infectivity for different CD4 alleles are shown in SI Appendix, Table S2).
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Piliocolobus badius), tantalus monkeys (SIVtan; Chlorocebus
tantalus), l’Hoest’s monkeys (SIVlho; Allochrocebus lhoesti), and
sooty mangabeys. Briefly, 293T cells were transfected with
plasmids expressing human and bonobo CD4 alleles as well as
their cognate CCR5 coreceptors, and then infected with viruses
pseudotyped with the various SIV Envs. Compared to human
CD4, both bonobo alleles were less efficient in mediating cell
entry (Fig. 1D and SI Appendix, Table S2), most likely because of
a glycan at position 32 (N32), which sterically hinders SIV Env
interaction in chimpanzees (55). However, all SIVcpz and SIV-
gor Envs, as well as most monkey SIV Envs, were able to utilize
both bonobo CD4 variants. The I83 allele was as efficient in
mediating cell entry as the chimpanzee QQNVP allele (SI Ap-
pendix, Fig. S3), which is not surprising given that the ectodo-
mains of these two CD4 molecules are identical (SI Appendix,
Fig. S2). The less frequent T83 allele appeared to enhance SIV
Env-mediated cell entry (SI Appendix, Table S2), although this
increase was only modest (on average 1.3-fold). Thus, bonobos
lack the extensive CD4 diversity that appears to protect chim-
panzees against primate lentiviruses. However, two Envs from
SIVmus and SIVsmm utilized the bonobo CD4 variants only
poorly (Fig. 1D). Although bonobos are not naturally exposed to
these viruses, this finding suggests that bonobos may be resistant
to some SIVs.
Western and Eastern Gorillas Encode Multiple D1 Domain Alleles. The
paucity of D1 domain polymorphisms in bonobos prompted us to
examine western and eastern (Gorilla beringei) gorillas, which
occupy nonoverlapping ranges in sub-Saharan Africa (SI Ap-
pendix, Fig. S1). Of these, only western lowland gorillas in
Cameroon are SIVgor infected, having acquired this virus only
once from sympatric chimpanzees (8, 11). Mining publicly
available genome databases (56, 60), we extracted complete CD4
protein sequences from 14 western and eastern lowland gorillas.
An alignment of these sequences revealed five polymorphic sites,
four of which were located in the D1 domain at positions 18 (A/













Chimpanzee (Pan troglodytes) 544‡ 9 + 6 1
Bonobo (Pan paniscus) 100§ 2 − 1 0
Western gorilla (Gorilla gorilla) 97§ 3 + 3 0
Eastern gorilla (Gorilla beringei) 25§ 2 − 3 0
Cercopithecine monkeys
L’Hoest’s monkey (Allochrocebus lhoesti) 3 2 + 2 0
Sun-tailed monkey (Allochrocebus solatus) 2 3 + 2 1
Tantalus monkey (Chlorocebus tantalus 11§ 3 + 3 0
Vervet monkey (Chlorocebus pygerythrus) 63§ 4 + 4 0
Grivet (Chlorocebus aethiops) 26§ 3 + 3 0
Green monkey (Chlorocebus sabaeus) 53§ 4 + 3 0
Malbrouck (Chlorocebus cynosuros) 16§ 4 + 3 0
Patas monkey (Erythrocebus patas) 5§ 1 − 0 0
Red-tailed monkey (Cercopithecus ascanius) 4{ 2 + 2 1
Mustached monkey (Cercopithecus cephus) 15 11 + 8 0
Greater spot-nosed monkey (Cercopithecus
nictitans)
17 9 + 8 1
Sykes’ monkey (Cercopithecus albogularis) 22 3 + 3 0
Blue monkey (Cercopithecus mitis) 7 3 + 3 0
De Brazza’s monkey (Cercopithecus neglectus) 3 1 + 0 0
Diana monkey (Cercopithecus diana) 5 3 ? 2 0
Lesser spot-nosed monkey (Cercopithecus
petaurista)
4 2 ? 2 0
Crested mona monkey (Cercopithecus pogonias) 2 2 − 1 0
Red-capped mangabey (Cercocebus torquatus) 3 2 + 4# 0
Sooty mangabey (Cercocebus atys) 5‡ 2 + 2# 0
Mandrill (Mandrillus sphinx) 7 2 + 1 1
Chacma baboon (Papio ursinus) 10 1 − 0 0
Olive baboon (Papio anubis) 13 1 − 0 0
Yellow baboon (Papio cynocephalus) 3 1 − 0 0
Colobine monkeys
Ugandan red colobus (Piliocolobus tephrosceles) 29§ 6 + 7 1
Mantled guereza (Colobus guereza) 4 2 + 1 1
*In addition to the within-species diversity shown here, D1 domain sequences were also obtained for single individuals of the following species: Preuss’s
monkey (Allochrocebus preussi), Hamlyn’s monkey Cercopithecus hamlyni), Lowe’s mona monkey (Cercopithecus lowei), Allen’s swamp monkey (Allenopi-
thecus nigroviridis), Angolan talapoin (Miopithecus talapoin), Drill (Mandrillus leucophaeus), and Angola colobus (Colobus angolensis) (see SI Appendix, Table
S5 for GenBank accession numbers).
†Plus sign (+), naturally SIV infected; minus sign (−) not naturally SIV infected; question mark (?), insufficient sampling to determine SIV infection status.
‡D1 domain sequences were obtained from GenBank.
§All or some D1 domain sequences were extracted from whole genome or RNA-seq datasets (24, 48, 68). Note that the number of D1 domain variants
represent minimum estimates, since alleles with low quality support were discarded.
{Minimum number of individuals from 25 samples.
#In addition to substitutions, a 3 bp deletion was observed in alleles of some red-capped and sooty mangabeys (Fig. 4A).
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P), 27 (H/N/R), 31 (S/P), and 34 (R/M), while the fifth was lo-
cated at position 142 (K/R) in the D2 domain (SI Appendix, Fig.
S4). All D1 domain polymorphisms were caused by SNPs in exon
2, which yielded five variants, three of which were only found in
western gorillas (AHSM, ARSM, ANSR), while the other two
were only found in eastern gorillas (AHPM, PRSM) (Table 1).
To determine whether these alleles represent the entirety of
D1 domain diversity, we used fecal DNA to sequence this region
in 90 additional western and 18 eastern lowland (G. beringei
graueri) gorillas sampled at 14 and 6 field sites throughout
Cameroon and the DRC, respectively (SI Appendix, Fig. S1).
Specimens were selected based on their geographic origin and
individual information, with both SIVgor+ SIVgor− western
lowland gorillas included (SI Appendix, Table S3). Like for the
bonobos, exons 2 and 3 were amplified separately because of the
large intervening intron and sequenced without fragmentation.
However, due to limited sample availability, some specimens
could only be amplified once (SI Appendix, Table S3). Consistent
with the genomic data, CD4 genotyping of wild gorillas con-
firmed the existence of AHSM, ARSM, and ANSR alleles in
western and AHPM and PRSM alleles in eastern lowland
gorillas, with no overlap between the two species (Fig. 2A). All
D1 polymorphisms were located at the binding interface of Env
and CD4 (Fig. 2B), with AHSM and AHPM representing the
most frequent alleles in western and eastern gorillas, respectively
(Fig. 2C). Although screening of wild gorillas did not uncover
additional CD4 diversity, it is clear that additional intermediate
alleles existed in these populations at some point in the past. For
example, the ANSR allele of western gorillas is 2 amino acids
different from its closest relatives, indicating three potential in-
termediates (AHSR, ANSM, ARSR), one of which must have
existed in the past, if not now (SI Appendix, Fig. S5). Similarly,
the AHPM and PRSM alleles in eastern gorillas differ by 3
amino acids, indicating six potential intermediates (AHSM,
ARSM, ARPM, PHPM, PRPM, PHSM), two of which are pre-
sent in western gorillas (SI Appendix, Fig. S5). Thus, there likely
are additional CD4 alleles in both gorilla species that have not
yet been identified.
To determine whether the D1 polymorphisms affected SIV
Env-mediated cell entry, we synthesized one gorilla CD4 allele
and generated the other D1 domain variants by site-directed




Fig. 2. Allelic diversity of CD4 in gorillas. (A) CD4 coding variants identified in western (G. gorilla gorilla; Ggg) and eastern (G. beringei graueri; Gbg) lowland
gorillas. D1 domain variants in exon 2 are compared to the human CD4, with dots indicating sequence identity (exon 3 derived protein sequences were
invariant). A potential N-linked glycosylation site is indicated by asterisks. Amino acid replacements are indicated in red, with allelic variants named based on
the order of polymorphic amino acid residues. (B) Crystal structure of the HIV-1 gp120 envelope domain (black) bound to human CD4 (gray) (PDB ID code
4R2G) with polymorphic positions indicated for chimpanzees (blue) and gorillas (red). (C) CD4 allele frequencies in wild-living western (Upper) and eastern
(Lower) gorillas. The number of tested individuals is indicated. (D) Effects of gorilla CD4 polymorphisms on SIV Env mediated cell entry. The infectivity of
pseudoviruses carrying the SIV Envs indicated is shown for transiently transfected cells expressing human and gorilla CD4 variants and the cognate CCR5
receptors. Values are scaled relative to human CD4 (set to 100%). Bars represent the average of two or three independent transfections, each performed in
triplicate, with SDs shown. MT145, MB897, EK505, LB715, and GAB2 represent SIVcpzPtt strains from central chimpanzees, while TAN2 and BF1167 represent
SIVcpzPts strains from eastern chimpanzees. (E) Protective effect of the N15 glycan. The percentage of infected cells bearing the AHSM allele was compared
to a mutant (N15T) lacking the N15 glycan (fold-changes of Env infectivity for different CD4 alleles are shown in SI Appendix, Table S4). Individual SIV Envs are
color coded as in D.
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expressing human and gorilla CD4, along with the corresponding
CCR5 coreceptors, and infected these cells with pseudoviruses
bearing the same SIV Envs used in the bonobo study. The results
showed that all gorilla CD4 alleles were functional and facili-
tated pseudovirus entry, although infectivity levels were again
lower compared to human CD4 (Fig. 2D). However, the five
gorilla CD4 alleles differed in their ability to facilitate infection.
For example, the ANSR allele mediated efficient entry of all
SIVgor Envs, while the AHPM allele reduced infection of two of
them (SI Appendix, Table S4). These allele-specific differences
were even more pronounced when SIVcpz Envs were tested. For
example, the MB897 Env utilized the AHSM and AHPM alleles,
but was restricted by the ARSM, ANSR, and PRSM alleles,
while the MT145 Env utilized the ARSM and PRSM alleles, but
was restricted by the AHSM, ANSR, and AHPM alleles
(Fig. 2D). Most, but not all, monkey SIV Envs utilized the five
gorilla CD4 alleles with high efficiency (Fig. 2D and SI Appendix,
Table S4). Thus, gorilla CD4 polymorphisms, like those in
chimpanzees, inhibit SIV Env cell mediated entry in a strain and
allele specific manner (55).
In addition to the five polymorphic sites, the gorilla CD4 en-
codes an invariant potential N-linked glycosylation site (PNGS)
at position 15 (N15) that is absent in all other primate species
(Fig. 2A). This PNGS, which has been experimentally confirmed
to be glycosylated (61), appears to occupy a similar structural
position as the chimpanzee glycan at position 66, which is known
to interfere with SIV Env binding (55). To examine whether N15
has a protective effect, we changed the asparagine at position 15
in one representative gorilla CD4 allele (AHSM) to a threonine,
which is present in all other African primates. Testing SIVgor,
SIVcpz, and other SIV Envs, we found that removal of the N15
glycan increased Env mediated infectivity on average by 1.6-fold
(SI Appendix, Table S4), with enhancement observed for nearly
every Env (Fig. 2E). Thus, like the invariant N32 glycan in
chimpanzees and bonobos, the invariant N15 glycan in gorillas
provides some degree of protection against SIV infection.
Mustached Monkeys Exhibit an Extraordinary Degree of CD4
Diversity. To examine whether CD4 diversity is unique to Afri-
can apes, we next sequenced the D1 domain in mustached
monkeys. We were particularly interested in this species because
mustached monkeys harbor three different types of SIVmus, two
of which represent recombinants with SIVgsn and other SIVs
(14, 62, 63), but are infected at very low (0 to 6%) prevalence
rates (2, 62, 64–66). Using remnant DNA from previous blood
collections (2, 64), we CD4-genotyped 15 members of this spe-
cies (Table 1). Sequence analysis of exons 2 and 3 identified eight
nonsynonymous SNPs, which resulted in amino acid replace-
ments at positions 30, 34, 39, 40, 41, 42, 50, and 90, the combi-
nation of which indicated a minimum of 11 different CD4 coding
variants (Fig. 3A). Of these, only nine D1 domain alleles could
be unambiguously inferred, because amplicons from the
remaining samples contained polymorphic sites in both exons 2
and 3. The combination of the latter resulted in at least two more
alleles as well as a possible third (Fig. 3A), although their exact
sequences could not be determined due to different possibilities
of exon 2 and 3 linkage. One polymorphic site (I34T) affected a
PNGS at position 32. Thus, analysis of a very small number of
mustached monkeys identified an extraordinary degree of D1
domain diversity, with 11 of the 15 animals exhibiting a hetero-
zygous CD4 genotype (SI Appendix, Table S5).
To examine whether the D1 domain polymorphisms affected
SIV Env-mediated cell entry, we generated a subset of mus-
tached monkey CD4 alleles (alleles 1 to 7) and tested these,
together with the cognate CCR5 coreceptor (67), in the single-
round infection assay (Fig. 3B). The results showed that all
mustached monkey CD4 variants mediated cell entry of the two
available SIVmus Envs. However, infectivity of the other SIV
Envs varied, with many utilizing only certain alleles (Fig. 3B and
SI Appendix, Fig. S6). A comparison of alleles that differed only
at position 34 (alleles 1 vs. 3 and 2 vs. 4) showed that a threonine
resulted in less-efficient entry than an isoleucine (SI Appendix,
Table S6), thus confirming the protective effect of the glycan at
position 32. Of all mustached monkey CD4 variants, allele 2 (the
inferred ancestral state) was the most permissive, mediating in-
fection even of an SIVdeb Env from De Brazza’s monkeys
(Cercopithecus neglectus), the only SIV Env that failed to use
human CD4. In contrast, allele 7 was the most restrictive, with
only three Envs being able to utilize this variant, two of which
were from SIVmus strains (SI Appendix, Table S6). Interestingly,
this allele encodes a proline at position 40, which is an Env
contact residue on human CD4 and the site of a protective Q40R
polymorphism in chimpanzees (55).
Within-Species CD4 Diversity Is Common among African Primates. To
determine how many other primates exhibit CD4 polymor-
phisms, we used remnant blood or fecal DNA from 124 members
of 23 additional African monkey species to amplify and sequence
the D1 domain (Table 1). These included samples from 22
Cercopithecine and one Colobine monkey species, 13 of which
are known to be naturally SIV-infected (SI Appendix, Table S5).
In addition, we extracted D1 domain sequences from published
RNA-sequencing (RNA-seq) data of 29 Ugandan red colobus
(48) and 4 patas monkeys (Erythrocebus patas) (47), and mined
whole-genome databases from 163 African green monkeys be-
longing to 5 different species (24). Finally, we obtained CD4
sequences from an Angolan colobus (Colobus angolensis), a drill
(Mandrillus leucophaeus), and five sooty mangabeys from Gen-
Bank. Together with the previously published chimpanzee data
(55), we were able to compare D1 domain sequences from 1,101
African primates representing 36 different species.
The various primate species exhibited a striking degree of CD4
diversity, both with respect to the number of species that had
CD4 polymorphisms and the number of alleles that were de-
tected. Of 29 species for which 2 or more individuals were gen-
otyped (Table 1), 24 (83%) encoded more than 1 D1 domain
variant, with many polymorphic sites located in putative Env–
CD4 contact residues (Fig. 4A). In fact, the great majority of
SNPs were nonsynonymous, with many species exhibiting no
synonymous changes in the D1 domain (Table 1). Greater spot-
nosed and mustached monkeys stood out as exhibiting the
highest CD4 diversity, with the largest number of D1 variants
identified (Table 1). Interestingly, identical polymorphisms were
found in members of different species and genera. For example,
the Q40R polymorphism, which was shown to affect Env–CD4
interaction in chimpanzees (55), was also found in two Cercopi-
thecus, one Piliocolobus, and one Cercocebus species (Fig. 4A). In
addition, two mustached monkey CD4 alleles exhibited a Q40P
mutation (Fig. 3A), which was also highly restrictive in the in-
fection assay (Fig. 3B). Although position 40 has not previously
been reported to be under positive selection (52, 53), the fre-
quent amino acid replacements at this site in distantly related
primate species indicates parallel evolution, most likely driven by
pathogenic SIV infections.
An alignment of D1 domain sequences also revealed that
certain CD4 variants were present in multiple closely related
primate species. L’Hoest’s and sun-tailed monkeys (genus Allo-
chrocebus) shared certain D1 alleles, as did various African green
monkey species, as well as different guenon species (SI Appendix,
Fig. S7). To compare the genealogy of CD4 with that of a
housekeeping gene, we used available genomic DNA to amplify
a 1.6-kb fragment of the glucose-6-phosphate dehydrogenase
(G6PD) gene from eight Cercopithecus species for which D1
domain sequences were also available (Fig. 4B). Phylogenetic
analysis of these sequences revealed species-specific clustering
and an overall topology that was very similar to phylogenies
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previously reported for these same primate species (68, 69).
However, this was not the case for the corresponding CD4 D1
domain sequences (Fig. 4C). Unlike the G6PD sequences, most
D1 domain sequences did not cluster according to their species,
but were intermixed, with one D1 domain allele shared by six
different species (Fig. 4C). These data suggest that the CD4
diversity found in these guenons predates their speciation, indi-
cating trans-specific polymorphism. Since D1 domain sequences
from different African green monkey species yielded similar
results (SI Appendix, Fig. S8), it appears that CD4 variants have
been maintained in various species by long-term balancing se-
lection (70, 71).
Most Primate CD4 Receptors Are Glycan Shielded. CD4 genotyping
of the various primates revealed a total of six potential N-linked
glycosylation sites within the D1 domain (SI Appendix, Fig. S7),
all of which were predicted to project toward the Env trimer
(Fig. 5A). A number of these seemed to be invariant within
species, such as the N17 glycan that was present in the great
majority of monkey species and the N15 glycan that was present
in all eastern and western gorillas (Fig. 5B). Other glycans were
polymorphic, such as the N21 glycan that was present in some,
but not all, Chlorocebus species. In fact, African green monkeys
exhibited three glycosylation sites in the D1 domain, but the
maximal number in any one variant was only two (SI Appendix,
Fig. S7). Certain glycans were unique to a particular species,
including the N66 of chimpanzees and the N39 glycan of man-
drills (Fig. 5B). The latter glycan is of interest since it is predicted
to protrude directly into the Env binding site and may thus
provide an explanation for the ability of SIVmnd1 to infect cells
that do not express the CD4 receptor (72). Three guenon and
two colobus species appeared to lack D1 domain glycans
A
B
Fig. 3. Allelic diversity of CD4 in mustached monkeys. (A) CD4 coding variants identified in mustached monkeys. Mustached monkey D1 domain variants
derived from both exons 2 and 3 (indicated on the bottom) are compared to one representative allele, with dots indicating identity to this reference (se-
quences are trimmed to the polymorphic region). Polymorphic positions are highlighted in red and their position is indicated on the top. Alleles 1 to 9 could
be unambiguously inferred; the remaining alleles remain ambiguous because of polymorphisms in both exons 2 and 3, which could not be linked. For in-
dividual 10, permutations of exons 2 and 3 combinations resulted in one new allele (either 10a or 10b), which was paired with an allele already identified in
other individuals. For individual 11, permutations resulted in either one new allele (11a) combined with an already known allele, or a combination of two new
alleles (11b and 12?). An N-linked glycosylation site is indicated by asterisks. An arrow marks allele 2, which is the inferred ancestral allele. (B) Effects of
mustached monkey CD4 polymorphisms on SIV Env mediated cell entry. A heatmap displays the percentage of cells expressing the indicated CD4 variant that
were infected by the corresponding SIV Env, averaged across two or three experiments each performed in triplicate (fold-changes of Env infectivity for
different CD4 alleles are shown in SI Appendix, Table S6).
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(Fig. 5B). However, these results are preliminary since in each
case only very few individuals were genotyped. Thus, unlike
humans, nearly all African primates encode at least one or more
N-linked glycosylation sites in their D1 domain, which are posi-
tioned to impede SIV infection by creating steric clashes with
glycans encoded by their Env glycoproteins.
Discussion
Unlike human CD4, chimpanzee CD4 is highly polymorphic with
nine D1 coding variants circulating in wild populations, all of
which are the result of replacements in the outermost domain
that binds the HIV/SIV Env trimer (55). Here, we show that
CD4 diversity is not unique to chimpanzees, but common among
African primates. Generating D1 domain sequences from over
500 monkeys and apes, we found polymorphic residues in 24 of
29 primate species, with as many as 11 different coding variants
identified within a single species (Table 1). Moreover, D1 do-
main mutations altered SIV Env-mediated cell entry. Although
the panel of Envs tested was not selected to examine specific SIV
exposure risks, the infectivity data show that D1 domain poly-
morphisms alter CD4–Env interactions. We also found identical
amino acid changes in species spanning multiple genera, such as
the Q40R polymorphism, which was observed in chimpanzees,
greater spot-nosed monkeys, Sykes’ monkeys, western red colo-
bus, and red-capped mangabeys (Fig. 4A), suggesting similar
selective pressures on CD4 in diverse African primates. Al-
though not all D1 domain variants were functionally tested,
those that reduce SIV infection in vitro likely do so by mecha-
nisms similar to those described for chimpanzees (55). In con-
trast, mechanisms that confer protection in vivo, both at the
individual and population level, are much less clear. It is possible
that SIV Env trimers that have to bind two different CD4 vari-
ants mediate cell entry less efficiently than Env trimers that need
to interact with only one, conferring a fitness advantage on in-
dividuals that are heterozygous for CD4 (55). Alternatively, a
virus adapted to one set of CD4 alleles may be less able to infect
an individual expressing a different set of CD4 alleles; then, as
viruses adapt to a set of common CD4 variants, they may not be
able to utilize rarer variants with similar efficiency. This could
result in negative frequency-dependent selection (70), which
could maintain CD4 diversity over a long timescale. Further
studies are required to differentiate between these, and other,
possibilities.
Unlike chimpanzees, bonobos are not naturally SIV-infected
(58), which may explain their limited CD4 diversity (Fig. 1).
However, bonobos are exposed to primate lentiviruses because
they hunt SIV-infected monkeys. Thus, bonobos may have
evolved mechanisms other than CD4 diversification to prevent
cross-species infections, such as restriction factors that act
downstream of the entry process. Alternatively, it is possible that
our SIV Env panel is not sufficiently representative of the SIV
strains that bonobos encounter. Although we identified two
monkey SIV Envs that were restricted by both bonobo alleles,
they do not represent relevant pathogens, because the ranges of
A
B C
Fig. 4. CD4 diversity in African primate species. (A) D1 domain positions exhibiting intraspecies polymorphisms. For each primate species, the positions of
polymorphic residues are shown, with the amino acid residues indicated. Dots indicate identity to the CD4 consensus, while dashes indicate deletions. Contact
residues between HIV-1 Env and human CD4 are indicated in red. (B and C) Maximum-likelihood trees of G6PD (B) and CD4 D1 domain (C) nucleotide se-
quences from different guenon species (color coded). Bootstrap values of >90% are shown; the scale bars indicate 0.001 and 0.004 nucleotide substitutions
per site, respectively.
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their hosts do not overlap that of bonobos. To examine whether
the two bonobo CD4 alleles have protective potential, it will be
necessary to isolate and test SIV Envs from monkey species that
are known to be hunted by bonobos, such as Thollon’s red
colobus (Piliocolobus tholloni), Wolf’s monkey (Cercopithecus
wolfii), and black crested mangabeys (Lophocebus aterrimus)
(57, 73).
Gorilla species also exhibit CD4 diversity, with western and
eastern gorillas encoding three and two CD4 variants, respec-
tively (Fig. 2). In both species, the differences among the hap-
lotypes indicate that additional variants have gone unsampled or
must have existed at some point in the past (SI Appendix, Fig.
S5). In particular, the AHPM and PRSM alleles in eastern go-
rillas necessitate at least two intermediate states, both of which
(AHSM and ARSM) are currently found in western gorillas. The
two species occupy disjunct ranges across central Africa, and it is
thus likely that the latter two CD4 alleles predate the split of the
two species (i.e., represent trans-specific polymorphisms). Since
we sequenced the D1 domain from both SIVgor+ and SIVgor−
western lowland gorillas, we asked whether there was an asso-
ciation between CD4 genotypes and SIVgor infection. Examin-
ing 60 gorillas from four sites (CP, BQ, DJ, BP), including
23 SIVgor-infected individuals, we failed to identify an excess of
CD4 heterozygosity in these communities (SI Appendix, Table
S3). It will thus be necessary to genotype larger numbers of both
infected and uninfected gorillas to determine whether certain
CD4 alleles, or allele combinations, are associated with lower
SIVgor infection rates as was observed previously for SIVcpz
infected chimpanzees (55). If protective polymorphisms are
identified, it would then be important to determine how they
confer protection at the individual level (e.g., by heterozygote
advantage) or at the population level (e.g., by negative frequency
dependent selection). Western gorillas are exposed to SIVgor,
and possibly also to SIVcpzPtt from sympatric central chimpan-
zees through fights and other physical interactions (11). In
contrast, eastern gorillas are not SIV-infected but may similarly
be exposed to SIVcpzPts from sympatric eastern chimpanzees.
Inhibition of the latter viruses by CD4 variants of eastern gorillas
may explain why this species exhibits CD4 diversity. It will thus
be important to test a larger number of SIVcpzPts strains for
their ability to utilize the AHPM and PRSM variants.
In addition to apes, we characterized CD4 variants from
mustached monkeys, which exhibited an extraordinary degree of
CD4 diversity, with 11 D1 domain variants identified in just 15
individuals. A similarly high number of D1 domain variants was
also found in greater spot-nosed monkeys, where 9 D1 domain
variants were identified in 17 individuals (Table 1). Mustached
monkeys forage in polyspecific troops with other SIV-infected
guenons, including greater spot-nosed, and mona monkeys (74,
75). Consistent with this, mustached monkeys harbor three dif-
ferent types of SIVmus, at least two of which are recombinants
with SIVgsn and other SIVs (14, 62). Despite their seemingly
high SIV exposure risk, mustached, greater spot-nosed, and
mona monkeys have very low infection rates, ranging from the
complete absence of SIV in some communities to 6% prevalence
in others (2, 62, 64–66). This is in contrast to other African
primate species, such as western red colobus (P. badius), where
prevalence rates of over 80% have been observed (76). It is thus
tempting to speculate that the extraordinary CD4 diversity in
mustached and greater spot-nosed monkeys reduces SIV trans-
mission, both within and between these species, by forcing
viruses to continuously adapt to different CD4 genotypes.
However, since other restricting mechanisms have also been
proposed (77), additional SIV prevalence and CD4 genotyping
studies, including of rarely sampled mona monkeys, are neces-
sary to determine to what extent CD4 diversity associates with
SIV infection in these guenons.
A
B
Fig. 5. D1 domain glycosylation in primates. (A) PNGS found in the D1
domain of different primate species. PNGS positions are modeled onto the
structure of the HIV-1 envelope trimer, with different protomers highlighted
in pink, green, and gray, respectively, and the bound human CD4 shown in
black (PDB ID code 5U1F). (B) Phylogeny of African primate species adapted
from Springer et al. (69). The tree highlights the presence of glycans within
each species, which are color coded as in A. Solid and striped squares indicate
invariant and polymorphic glycans, respectively. The scale bar indicates es-
timated primate divergence times as previously reported (69).
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All SIV Envs tested here and in our previous study (55) uti-
lized human CD4 more efficiently than chimpanzee, bonobo, or
gorilla CD4 alleles (Figs. 1 and 2), most likely because of the
absence of D1 domain glycans in the human protein. However,
one Env from a virus naturally infecting De Brazza’s monkeys
failed to infect cells expressing human CD4, including TZM-bl
cells, a HeLa cell line engineered to stably express human CD4,
CCR5, and CXCR4 at high levels (78). Surprisingly, when this
same SIVdeb Env was tested on cells transiently transfected with
mustached monkey CD4, it was able to utilize two variants (al-
leles 2 and 5) efficiently, one of which (allele 2) is identical at the
amino acid level to the De Brazza CD4 observed in this study
(Fig. 4C). These data indicate that human CD4, despite lacking
D1 domain polymorphisms and glycans, still serves as an entry
barrier for some SIV Envs.
A comparison of CD4 sequences among the various primate
species also provided evidence of trans-specific polymorphism.
Within each of the three genera—Allochrocebus, Cercopithecus,
and Chlorocebus—D1 domain sequences did not form species-
specific clades (Fig. 4C and SI Appendix, Fig. S8). Instead,
identical coding variants were identified in closely related spe-
cies, suggesting that they predated the emergence of these spe-
cies. In the case of very closely related species, such as African
green monkeys, it could be argued that the sharing of D1 domain
alleles is the result of incomplete lineage sorting. However, this
explanation is highly unlikely for the Cercopithecus genus.
Among 11 guenon species, all except Diana monkeys (Cercopi-
thecus diana) shared identical D1 domain variants, including one
that was found in nine different species (SI Appendix, Fig. S8).
Interestingly, this variant (designated allele 2 in Fig. 3A) was the
most permissive in mustached monkeys (Fig. 3B) and clustered
ancestral to all other D1 domain alleles from these nine species
(SI Appendix, Fig. S8). Its permissive phenotype may thus reflect
the fact that SIVs have had the longest time to adapt to it.
Among animals, only a limited number of trans-specific poly-
morphisms have been described, most of which involve immune
genes where heterozygosity appears to confer resistance to
pathogens, leading to long-term balancing selection (71, 79). The
trans-specific polymorphisms at the CD4 locus in Cercopithecus
involve species estimated to have shared a common ancestor 6 to
7 Mya (69, 80), which is consistent with selection maintaining
CD4 diversity over a long timescale.
Although genotyping 26 individuals, we failed to detect CD4
polymorphisms in members of three baboon species (Table 1).
Baboons are not naturally SIV-infected, but are susceptible to
SIVagm, having acquired this virus from sympatric African green
monkeys on rare occasions in the wild (81–83). Since all of these
acquisitions appear to represent dead-end infections with no
secondary spread, it is likely that baboons have acquired anti-SIV
defenses downstream of the entry process. Humans, who also
lack D1 domain diversity, have evolved restriction factors that
target HIV/SIV at multiple steps in the viral life cycle. For ex-
ample, tetherin, which limits HIV/SIV viral egress from infected
cells, is believed to protect humans from zoonotic SIV infections
because of a unique 5-amino acid deletion in the cytoplasmic
domain that prevents the binding of SIV Nef proteins that
counteract tetherin (84, 85). Hence, both humans and baboons
may have evolved protective mechanisms that reduce the need
for CD4 diversification, although in both species protection from
SIV infection has not been absolute. It is also possible that in
humans and baboons D1 domain polymorphisms are not com-
patible with some of the physiological functions of CD4, and are
thus not tolerated.
Given that primate lentiviruses have zoonotic potential, it is
important to identify and understand factors that limit their
spread. The results of this and our previous study (55) suggest
that CD4 receptor diversity reduces SIV infection at the pop-
ulation level and might even guard against cross-species
infection. While several lines of evidence point to lentiviruses as
the driving force of the CD4 diversification in primates, other
CD4 tropic pathogens cannot be excluded. Indeed, human her-
pesvirus 7 (HHV-7) has been shown to require CD4 for entry
into target cells (86) and related viruses infect wild apes (87).
Although HHV-7 appears to be benign, there could be other
pathogens, both extant and extinct, which require attachment to
the D1 domain of CD4 to infect target cells. However, irre-
spective of the forces that have been driving CD4 diversification,
it seems clear that existing polymorphisms alter SIV Env–CD4
interactions and in some instances afford protection from SIV
infection. These data add to a growing body of evidence sug-
gesting that primate lentiviruses have been exerting selective
pressure on their hosts for millions of years. However, the re-
tention of functional CD4 diversity also suggests that balancing
selection is still ongoing and protects present day primates from
pathogenic SIV infections.
Methods
Nonhuman Primate Samples. CD4 and G6PD genotyping was performed using
remnant DNA from blood or fecal samples collected previously from both
wild-caught and captive primates for molecular epidemiological studies of
SIV and Plasmodium infections. All samples were obtained with the approval
of the respective Institutional Animal Care and Use Committees. Interna-
tional samples were shipped in compliance with Convention on Interna-
tional Trade in Endangered Species of Wild Fauna and Flora regulations and
country-specific import and export permits. Relevant information for all
samples is summarized in SI Appendix, Tables S1, S3, and S5.
D1 Domain Genotyping. CD4 genotyping was carried out as previously de-
scribed (55). Briefly, CD4 exon 2 (165 bp) and exon 3 (159 bp) were PCR-
amplified using primers in adjacent introns resulting in amplicons that were
247 bp and 222 bp in length, respectively. Amplicons were MiSeq sequenced
without fragmentation to ensure linkage of variable sites for each exon.
Assembly of CD4 Genes from Bonobo and Gorilla Genomic Databases. Whole-
genome Illumina sequencing reads from bonobos and gorillas were down-
loaded from the National Center for Biotechnology Information (NCBI) da-
tabase (56) and from the European Nucleotide Archive (60).
Extraction of D1 Domain Sequences from Monkey RNA-Seq and Genomic
Databases. RNA-seq reads from red colobus monkeys (48) were down-
loaded from the NCBI Sequence Read Archive (SRA) from BioProject
PRJNA413051 and aligned as described in SI Appendix. Reads from African
green monkey genome datasets (24) were gathered from NCBI SRA Bio-
Projects PRJNA168472, PRJNA168520, PRJNA168527, PRJNA168522,
PRJNA168521, PRJNA362602, and PRJNA407948. RNA-seq reads from patas
monkeys, aligned to the Macaca mulatta chromosome 11 (accession
NC_027903.1), were provided by the authors (47). Consensus sequence ex-
traction proceeded as for the African green monkeys.
Expression Plasmids and Pseudovirus Stocks. The construction of an
SIVcpzΔenv reporter backbone and several SIV Envs were previously repor-
ted (55). Codon optimized SIVgor, SIVgsn, SIVmon, and SIVdeb env genes
were synthesized and cloned into pcDNA3.1. SIV Env pseudotypes were
produced in 293T cells by cotransfection of SIVcpzΔenv-GFP and SIV env
expression plasmids and titered on TZM-bl cells. Full-length chimpanzee CD4
was mutagenized to obtain the bonobo CD4 clone. Full-length gorilla CD4
was synthesized based on genomic sequences. Chimpanzee CCR5 was muta-
genized to match bonobo (XM_034956280) and gorilla (XM_004034016)
GenBank sequences. The generation of mustached guenon CD4 and CCR5
expression plasmids has previously been described (67). CD4 polymorphisms
were introduced by site-directed mutagenesis into one parental plasmid to
obtain multiple D1 domain variants. All CD4 and CCR5 alleles were cloned
into pcDNA3.1.
Transient CD4 Transfection Assay. Env-mediated entry was measured as pre-
viously described (55). Briefly, 293T cells were transfected with the various
CD4 alleles, along with the species-matched CCR5, infected with SIV Env
bearing pseudoviruses, and then analyzed for GFP expression by flow
cytometry 2 d post infection. CD4 and CCR5 expression levels were
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determined at the time of infection using receptor specific antibodies (e.g.,
SI Appendix, Fig. S9).
Phylogenetic Analyses. Sequence alignments were trimmed to the same start
and end position (297 bp or 99 aa for CD4 D1 domain, 1,584 bp for G6PD). For
G6PD sequences, regions with indels causing ambiguity in the alignment
were removed. Maximum-likelihood trees were constructed using RaxML
v8.2.12 (88) with 100 rapid bootstrap replicates, with model GTRGAMMA for
nucleotide sequences and PROTGAMMAJTTF for amino acid sequences.
Statistical Analyses. A hierarchical Bayesian model was used to assess the
effects of CD4 polymorphisms on SIV Env-mediated cell entry (SI Appendix).
The effects of the various alleles on the infectivity of each Env, as well as an
overall allele effect, was estimated by Markov chain Monte Carlo sampling
using Stan (89).
Data Availability. Primate CD4 exons 2 and 3 sequences and G6PD sequences
have been deposited in GenBank (accession nos. MW514379–MW514444,
MW535772, and MW535773). Analysis code is archived on Zenodo (https://
doi.org/10.5281/zenodo.4602351). All other study data are included in the
article and SI Appendix.
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